Barclays lowered the firm’s price target on Clorox (CLX) to $102 from $109 and keeps an Underweight rating on the shares. The firm adjusted targets in the consumer staples group as part of a Q1 preview. Barclays has “growing caution” on the group into the prints due to higher input costs. In food, there are now “building concerns” around the sustainability of the dividend for certain companies, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $112 from $124 at BofA
- Clorox price target lowered to $127 from $132 at RBC Capital
- Clorox price target lowered to $110 from $125 at Wells Fargo
- Clorox price target lowered to $110 from $121 at UBS
- Balanced Risk-Reward on Clorox: Limited Near-Term Upside Despite GOJO-Driven Revenue Boost and ERP-Inflated Growth Comparisons
